insulin aspart-szjj
insulin aspart-szjj is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including MERILOG. Available dosage form: injection, solution.
Drug Details
- Generic Name
- insulin aspart-szjj
- Brand Names
- MERILOG
- Application Number
- BLA761325
- Sponsor
- Sanofi-Aventis Deutschland GmbH
- NDC Codes
- 4
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Active Ingredients
- INSULIN ASPART
Indications and Usage
1 INDICATIONS AND USAGE MERILOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. MERILOG is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ).